DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dificid (Fidaxomicin) - Published Studies


Dificid Related Published Studies

Well-designed clinical trials related to Dificid (Fidaxomicin)

Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin. [2013]

Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. [2012]

Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection. [2012]

Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection. [2012]

Fidaxomicin: a macrocyclic antibiotic for the management of Clostridium difficile infection. [2010]

Well-designed clinical trials possibly related to Dificid (Fidaxomicin)

Effect of age on treatment outcomes in Clostridium difficile infection. [2013]

Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. [2012]

Other research related to Dificid (Fidaxomicin)

Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic. [2013]

Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. [2012]

Fidaxomicin for Clostridium difficile-associated diarrhoea: epidemiological method for estimation of warranted price. [2012]

Efficacy and safety of fidaxomicin compared with oral vancomycin for the treatment of adults with Clostridium difficile-associated diarrhea: data from the OPT-80-003 and OPT-80-004 studies. [2012]

Fidaxomicin: first-in-class macrocyclic antibiotic. [2011]

Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection. [2009]

Other possibly related research studies

[Challenges of Clostridium difficile infection]. [Article in German] [2013]

New developments in chemotherapeutic options for Clostridium difficile colitis. [2013]

Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials. [2013]

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. [2011]

Emerging therapies for Clostridium difficile infections. [2011]

Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. [2010]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017